-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Batoclimab in Graves Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Batoclimab in Graves Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Batoclimab in Graves Diseases Drug Details: Batoclimab is under development for the...
-
Product Insights
Peanut Allergy – Drugs In Development, 2023
Global Markets Direct’s, ‘Peanut Allergy - Drugs In Development, 2023’, provides an overview of the Peanut Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Peanut Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Food Allergy – Drugs In Development, 2023
Global Markets Direct’s, ‘Food Allergy - Drugs In Development, 2023’, provides an overview of the Food Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Food Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ZL-1211 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ZL-1211 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ZL-1211 in Solid Tumor Drug Details: ZL-1211 is under development for...
-
Product Insights
Transdermal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transdermal Drug Delivery Pipeline Market Report Overview Transdermal drug delivery devices are medicated adhesive patches placed on the skin to deliver a specific dose of medication through the skin into the bloodstream. The Transdermal Drug Delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Company Profile
DBV Technologies SA – Company Profile
DBV Technologies SA (DBV Technologies) is a biopharmaceutical company. It develops self-administered and non-invasive therapies to treat food allergies and other immunological diseases. Its product pipeline includes Viaskin peanut, Viaskin milk and Viaskin EoE indicated for the treatment of related food allergies in children. It offers clinical trial services which comprises food allergy clinical trials, milk clinical trials, egg pre clinical studies and peanut clinical trials. It markets its products under the brand such as Viaskin. DBV Technologies seeks to...
Add to Basket -
Product Insights
Peanut Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy – Drugs In Development, 2022, provides an overview of the Peanut Allergy (Immunology) pipeline landscape. Peanut allergy is common, especially in children. An allergic response to peanuts usually occurs within minutes after exposure, and symptoms range from mild to severe. Peanut allergy signs and symptoms can include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such...
-
Sector Analysis
Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
Food Allergy Market Overview The food allergy market was valued at $213.9 million in 2020 globally and is forecast to grow at a CAGR of more than 28% during the forecast period. Food Allergy Market Overview, 2020-2030 ($Million) For more insights into the food allergy market forecast, download a free report sample The food allergy market lacks a curative agent, with the only available treatments being antihistamines or epinephrine usage for accidental exposure. The food allergy pipeline consists of 31...
-
Sector Analysis
Eosinophilic Esophagitis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Stratergies and Forecast, 2020 – 2030
The eosinophilic esophagitis (EoE) market in the US was valued at $156.7 million in 2020. The market is projected to grow at a CAGR of more than 25% during the forecast period. The COVID-19 pandemic did not impact the EoE market in 2020. Although the uptake of high-priced biologics is expected to be slow, they are expected to capture significant growth revenue over the next 10 years. A large number of symptomatic treatments are currently used off-label. The most frequently...
-
Product Insights
Peanut Allergy – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Peanut Allergy - Global Clinical Trials Review, H2, 2021" provides an overview of Peanut Allergy Clinical trials scenario. This report provides top line data relating to the clinical trials on Peanut Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...